These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20871028)

  • 1. Recovery from immunosuppression-related disorders in humans and animals by IP-PA1, an edible lipopolysaccharide.
    Hebishima T; Matsumoto Y; Watanabe G; Soma G; Kohchi C; Taya K; Hayashi Y; Hirota Y
    Anticancer Res; 2010 Aug; 30(8):3113-8. PubMed ID: 20871028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of the immunopotentiator from Pantoea agglomerans 1 on chemotherapeutic agent-induced macrophage growth inhibition.
    Hebishima T; Matsumoto Y; Watanabe G; Soma G; Kohchi C; Taya K; Hayashi Y; Hirota Y
    Anticancer Res; 2010 Jun; 30(6):2033-40. PubMed ID: 20651348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recovery effects of immunopotentiator from Pantoea agglomerans 1 (IP-PA1) on low antibody productions in response to Salmonella enteritidis vaccine and sheep red blood cells in dexamethasone-treated stressed chicken models.
    Hebishima T; Matsumoto Y; Soma G; Kohchi C; Watanabe G; Taya K; Hayashi Y; Hirota Y
    J Vet Med Sci; 2010 Apr; 72(4):435-42. PubMed ID: 20035113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide IP-PA1 from Pantoea agglomerans prevents suppression of macrophage function in stress-induced diseases.
    Nakata K; Inagawa H; Soma G
    Anticancer Res; 2011 Jul; 31(7):2437-40. PubMed ID: 21873156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) for health care based on macrophage network theory.
    Kohchi C; Inagawa H; Nishizawa T; Yamaguchi T; Nagai S; Soma G
    J Biosci Bioeng; 2006 Dec; 102(6):485-96. PubMed ID: 17270712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of immunopotentiator from Pantoea agglomerans 1 (IP-PA1) improves the survival of B16 melanoma-inoculated model mice.
    Hebishima T; Matsumoto Y; Watanabe G; Soma G; Kohchi C; Taya K; Hayashi Y; Hirota Y
    Exp Anim; 2011; 60(2):101-9. PubMed ID: 21512265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and potential use of a monoclonal antibody to the lipopolysaccharide of Pantoea agglomerans (IP-PA1).
    Taniguchi Y; Nishizawa T; Honda T; Yoshioka N; Inagawa H; Kohchi C; Soma G
    Anticancer Res; 2007; 27(6A):3701-6. PubMed ID: 17970031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of lipopolysaccharide derived from Pantoea agglomerans labeled with fluorescence as a tracer for kinetics analysis.
    Kadowaki T; Inagawa H; Kohchi C; Hirashima M; Soma G
    Anticancer Res; 2010 Aug; 30(8):3151-7. PubMed ID: 20871034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of allergic dermatitis via regulation of the Th1/Th2 immune system balance by macrophages activated with lipopolysaccharide derived from Pantoea agglomerans (IP-PA1).
    Yoshida A; Kohchi C; Inagawa H; Nishizawa T; Soma G
    Anticancer Res; 2009 Nov; 29(11):4867-70. PubMed ID: 20032449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopotentiator from Pantoea agglomerans 1 (IP-PA1) Promotes Murine Hair Growth and Human Dermal Papilla Cell Gene Expression.
    Wakame K; Okawa H; Komatsu KI; Nakata A; Sato K; Ingawa H; Kohchi C; Nishizawa T; Soma G
    Anticancer Res; 2016 Jul; 36(7):3687-92. PubMed ID: 27354641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunological analysis of innate immunity activation after oral administration of wheat fermented extract to teleost fish.
    Kadowaki T; Yasui Y; Takahashi Y; Kohchi C; Soma G; Inagawa H
    Anticancer Res; 2009 Nov; 29(11):4871-7. PubMed ID: 20032450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility and safety of LPS-based fermented flour extract as a macrophage activator.
    Taniguchi Y; Yoshioka N; Nishizawa T; Inagawa H; Kohchi C; Soma G
    Anticancer Res; 2009 Mar; 29(3):859-64. PubMed ID: 19414320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantoea agglomerans: a mysterious bacterium of evil and good. Part IV. Beneficial effects.
    Dutkiewicz J; Mackiewicz B; Lemieszek MK; Golec M; Milanowski J
    Ann Agric Environ Med; 2016 Jun; 23(2):206-22. PubMed ID: 27294621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Ah receptor-mediated polychlorinated biphenyl (PCB)-induced humoral immunosuppression and thymic atrophy.
    Silkworth JB; Antrim L
    J Pharmacol Exp Ther; 1985 Dec; 235(3):606-11. PubMed ID: 3001270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immune response by bacterial lipopolysaccharide (LPS): multifocal effects of LPS-induced suppression of the primary antibody response to a T-dependent antigen.
    Uchiyama T; Jacobs DM
    J Immunol; 1978 Dec; 121(6):2340-6. PubMed ID: 363944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
    Inagawa H; Nishizawa T; Noguchi K; Minamimura M; Takagi K; Goto S; Soma G; Mizuno D
    Anticancer Res; 1997; 17(3C):2153-8. PubMed ID: 9216680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate analgesics contribute to the development of post-injury immunosuppression.
    Alexander M; Daniel T; Chaudry IH; Schwacha MG
    J Surg Res; 2005 Nov; 129(1):161-8. PubMed ID: 16139307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis.
    Lee CH; Wu CL; Shiau AL
    Clin Cancer Res; 2008 Mar; 14(6):1905-12. PubMed ID: 18347194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo.
    Kopydlowski KM; Salkowski CA; Cody MJ; van Rooijen N; Major J; Hamilton TA; Vogel SN
    J Immunol; 1999 Aug; 163(3):1537-44. PubMed ID: 10415057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
    Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
    Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.